Citation 83457

CUI,BL: LEE,YH: CHAI,HB: TUCKER,JC: FAIRCHILD,CR: RAVENTOS-SUAREZ,C: LONG,B: LANE,KE: MENENDEZ,AT: BEECHER,CWW: CORDELL,GA: PEZZUTO,JM: KINGHORN,AD:. (1999). CYTOTOXIC SESQUITERPENOIDS FROM RATIBIDA COLUMNIFERA.. 62(11)

Citation Details

Title	CYTOTOXIC SESQUITERPENOIDS FROM RATIBIDA COLUMNIFERA.
Authors	CUI,BL: LEE,YH: CHAI,HB: TUCKER,JC: FAIRCHILD,CR: RAVENTOS-SUAREZ,C: LONG,B: LANE,KE: MENENDEZ,AT: BEECHER,CWW: CORDELL,GA: PEZZUTO,JM: KINGHORN,AD:
Year	1999
Volume	62
Issue	11

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (2)

Ratibida columnifera (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	BACTERIAL STIMULANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	STRONG ACTIVITY
3	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	STRONG ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	STRONG ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	STRONG ACTIVITY
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	STRONG ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	STRONG ACTIVITY
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	STRONG ACTIVITY
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RATIFEROLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-ANGELATE	INACTIVE
17	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	EQUIVOCAL
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	EQUIVOCAL
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	EQUIVOCAL
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	EQUIVOCAL
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-8(R)-9(S)-EPOXY-1(S)-HYDROXY-2-OXO:	INACTIVE
31	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	None
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	EQUIVOCAL
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	ACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	EQUIVOCAL
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	ACTIVE
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	ACTIVE
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	STRONG ACTIVITY
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-1(S)-HYDROXY-2-OXO:	INACTIVE
45	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	None
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	ACTIVE
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	EQUIVOCAL
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	ACTIVE
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	EQUIVOCAL
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	WEAK ACTIVITY
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	ACTIVE
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	ACTIVE
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	ACTIVE
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	EQUIVOCAL
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	STRONG ACTIVITY
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	ACTIVE
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	EQUIVOCAL
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHA-3-11-DIEN-6(R)-12-OLIDE,5(S)-ANGELOYL-OXY-1(S)-8(S)-DIHYDROXY-2-OXO: 8(S)-10(S):	INACTIVE
59	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	None
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	STRONG ACTIVITY
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	STRONG ACTIVITY
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
72	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE)	INACTIVE
73	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	None
74	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	WEAK ACTIVITY
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	WEAK ACTIVITY
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	WEAK ACTIVITY
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	EQUIVOCAL
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	ACTIVE
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	ACTIVE
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	WEAK ACTIVITY
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	WEAK ACTIVITY
82	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	EQUIVOCAL
83	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	WEAK ACTIVITY
84	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	EQUIVOCAL
85	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEROLIDOL,12-ACETOXY-5-HYDROXY:	ACTIVE
86	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NEROLIDOL,12-ACETOXY-5-HYDROXY:	INACTIVE
87	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HISPIDULIN	None
88	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	WEAK ACTIVITY
89	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	ACTIVE
90	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	WEAK ACTIVITY
91	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	ACTIVE
92	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	WEAK ACTIVITY
93	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	ACTIVE
94	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	ACTIVE
95	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	WEAK ACTIVITY
96	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	WEAK ACTIVITY
97	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	WEAK ACTIVITY
98	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	ACTIVE
99	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HISPIDULIN	WEAK ACTIVITY
100	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	INACTIVE

Ratibida columnifera (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	BACTERIAL STIMULANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	STRONG ACTIVITY
3	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	STRONG ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	EQUIVOCAL
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	EQUIVOCAL
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	EQUIVOCAL
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	STRONG ACTIVITY
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	EQUIVOCAL
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	EQUIVOCAL
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RATIFEROLIDE,SECO: 9-OXO: 5-ALPHA-O-(2-METHYL-BUTYRATE):	INACTIVE
17	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	ACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	EQUIVOCAL
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	EQUIVOCAL
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	WEAK ACTIVITY
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	EQUIVOCAL
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	STRONG ACTIVITY
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	EQUIVOCAL
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	EQUIVOCAL
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTH-11-EN-6(R)-12-OLIDE,1(S)-HYDROXY-4-METHOXY-5(S)-METHYL-BUTANOYL-OXY-2-9-DIOXO: 7(S):	INACTIVE
31	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	None
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	WEAK ACTIVITY
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	EQUIVOCAL
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	WEAK ACTIVITY
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	EQUIVOCAL
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	WEAK ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	WEAK ACTIVITY
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	WEAK ACTIVITY
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	EQUIVOCAL
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	WEAK ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	EQUIVOCAL
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	EQUIVOCAL
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTH-11-EN-6(R)-12-OLIDE,5(S)-METHYL-BUTANOYL-OXY-1(S)-4-9(R)-TRIHYDROXY-2-OXO: 7(S):	INACTIVE
45	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	None
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	STRONG ACTIVITY
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	STRONG ACTIVITY
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	ACTIVE
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	STRONG ACTIVITY
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	STRONG ACTIVITY
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	EQUIVOCAL
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RATIFOLIDE,SECO: 9-ALPHA-HYDROXY: 5-ALPHA-O-(2-METHYL-BUTYRATE)	INACTIVE

Citation 83457

Citation Details

Summary

Organisms and Their Experiments (2)

Ratibida columnifera (ASTERACEAE)

Ratibida columnifera (ASTERACEAE)

Show SPARQL Queries (1)

Query 1